Summary by Moomoo AI
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 11/16/2024, indicates that Shah does not beneficially own any securities in the company. The filing, which is a standard regulatory requirement for officers, directors, and 10% owners, provides transparency about the holdings of company insiders. Shah's filing was completed on 11/18/2024 and is part of the compliance with Section 16(a) of the Securities Exchange Act of 1934.
